Complete financial analysis of Primavera Capital Acquisition Corporation (PV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Primavera Capital Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- Amco India Limited (AMCOIND.BO) Income Statement Analysis – Financial Results
- Hochiki Corporation (6745.T) Income Statement Analysis – Financial Results
- NuStar Energy L.P. (NS) Income Statement Analysis – Financial Results
- Myriad Genetics, Inc. (0K3W.L) Income Statement Analysis – Financial Results
- RiskOn International, Inc. (ROII) Income Statement Analysis – Financial Results
Primavera Capital Acquisition Corporation (PV)
About Primavera Capital Acquisition Corporation
Primavera Capital Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in consumer companies China. The company was incorporated in 2020 and is based in Central, Hong Kong.
Metric | 2021 |
---|---|
Revenue | 0.00 |
Cost of Revenue | 0.00 |
Gross Profit | 0.00 |
Gross Profit Ratio | 0.00% |
Research & Development | 0.00 |
General & Administrative | 3.46M |
Selling & Marketing | 0.00 |
SG&A | 3.46M |
Other Expenses | 0.00 |
Operating Expenses | 3.46M |
Cost & Expenses | 3.46M |
Interest Income | 0.00 |
Interest Expense | -24.34M |
Depreciation & Amortization | 24.34M |
EBITDA | 20.88M |
EBITDA Ratio | 0.00% |
Operating Income | -3.46M |
Operating Income Ratio | 0.00% |
Total Other Income/Expenses | 24.34M |
Income Before Tax | 20.88M |
Income Before Tax Ratio | 0.00% |
Income Tax Expense | -24.34M |
Net Income | 45.21M |
Net Income Ratio | 0.00% |
EPS | 0.84 |
EPS Diluted | 0.84 |
Weighted Avg Shares Out | 53.75M |
Weighted Avg Shares Out (Dil) | 53.75M |
ees Europe: Battery Storage – Powerbanks for the Energy Transition
BESREMi® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO
Ampt Completes Delivery to Edison Power for Solar+Storage Microgrid Project Being Developed by Tocoo, Inc. in Japan
New ropeginterferon alfa-2b Data Suggest Alternate Dosing Schedule May Achieve Greater and Quicker Complete Hematologic and Molecular Responses in Polycythemia Vera
JA Solar and BayWa r.e. Sign Strategic Solar Module Distribution Cooperation Agreement for Asia-Pacific Region
Ampt Completes Repowering Project in Japan Allowing PV System to Meet New Utility Requirements
JA Solar is Named the Top Performer Module Supplier by PVEL for the Eighth Time
TotalEnergies ENEOS to Acquire Sao Mai Solar Rooftop Portfolio and Sign MOU for Further Cooperation Opportunities
PharmaEssentia Selects Pint-Pharma as Commercial Partner for BESREMi® (ropeginterferon alfa-2b-njft) in Latin America
Sunport Power Brings Its Latest Full Black Flexible PV Module Based On MBC2.0 Technology to SNEC 2023
Source: https://incomestatements.info
Category: Stock Reports